Search - tctmd.com

Displaying 781 - 800 of 841

Sort: Relevancy | Date

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

L.A. McKeown

March 05, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

Presentation

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Presenter: Takeshi Kimura

January 08, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

November 16, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Genetic Predictors of Early Stent Thrombosis Identified

L.A. McKeown

October 25, 2011

News Daily News

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

September 19, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Daily News

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

L.A. McKeown

August 19, 2011

Advertisement

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

SCAAR: Second-Generation DES Improve Hard Outcomes

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Genetic Predictors of Early Stent Thrombosis Identified

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Novel Anticoagulants Showing Benefits in A-fib Subgroups

New-Generation DES Reduce Restenosis, Stent Thrombosis

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content